On 29 january, china's new network, heilongjiang news (lao ho), held a working session on market regulation (pharmaceuticals, intellectual property) in harbin. Over the past few days, the municipal (local) pharmacological departments have been rapidly learning to follow up on the conference and have planned and focused work on the deployment and follow-up of specific initiatives to ensure that the “fifty-five” has a good start。
The market regulatory authority of the high-hinging and the middle east region
Following the spirit of the conference, particularly the deployment of the director of the provincial drug supervisory authority, li jin-soon, to define the objectives of the drug regulatory authority for 2026 and to lay the foundation for a good start to the regulation of drugs for 2026; define the time nodes and work patterns to be implemented at a hierarchical level, in line with the requirements of the five actions of drug control; ensure the integration of ideas and actions into the decision-making process of the provincial drug regulatory authority; and improve risk prevention and control mechanisms and effectiveness mechanisms to accelerate the application of intellectual monitoring platforms and to establish safety thresholds for the quality of medicines。
Police division, municipal markets authority
The organization of an in-depth study on the drug regulatory front in order to draw attention to the requirements for the deployment of the provincial drug control service, to grasp the core of the new era's “five-step-by-one” approach to drug regulation, and to place drug security at the centre of public security. To take stock of the experience of “prevent, control and combat” three-dimensional efforts to establish safe lines for medicines, to ensure that the safety floor and service development are closely integrated, to strengthen risk prevention and control and to stimulate dynamism and intensity; to ensure that day-to-day regulation is combined with long-term governance and that wisdom is used to promote prevention in the first place; to improve professional capacity and ensure that medicines are safe and accessible to the population; and to promote “fifty-five” efforts to regulate medicines in the city of kontanjiang to start the process。
Zizihar city market supervisory authority
Learning from the province-wide drug regulatory conference, the conference has provided guidance on measures such as deepening the hierarchy of regulations, extending the “clean-up” of the drug chain, and strengthening the control of digital traceability and specific drugs. The implementation of the “one-calorie list” system is consistent with the risk loop, maintaining the “slotting” threshold, “card” accountability, “single” risk management, digital enabling dynamic management, linking the “source clean-up” of drug operations with hierarchical regulation, network patrols, execution of sentences, and making a leap towards “multiplier” and securing the use of safety thresholds in drug operations。
Superintendence of black river markets
Four major initiatives on drug regulation were implemented in conjunction with local practical studies. The establishment of a secure line of defence, the deepening of the "closing the whole chain" operation, the focus on critical aspects of drug use, the development of checklists, the strengthening of risk management and the safety of the population; the optimization of service performance, the introduction of “one-size-fits-all” guidance and the promotion of high-quality industry development in response to the characteristics of pharmaceutical enterprises; the upgrading of the level of supervision, the promotion of the application of the "rongjiang drug monitoring and information centre" micro-procedure, the improvement of the drug traceability system, the strengthening of the operational training of supervisors and the promotion of greater regulatory effectiveness; the maintenance of a clean baseline, the robust monitoring mechanism for the operational control of regulatory powers, the creation of a dedicated and clean chain of supervision and the provision of strong disciplinary guarantees for the safety of medicines. (concluded)
